Heron Therapeutics (LTS:0J4V) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0J4V Heron Therapeutics Inc LTS:0J4V
50 GF Score
Price $0.48
GF Value $1.55
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Heron Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0J4V
50GF Score
Heron Therapeutics Inc LTS:0J4V
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Heron Therapeutics (LTS:0J4V) Overvalued in 2026?

Based on GuruFocus' analysis, Heron Therapeutics stock appears to be undervalued. The current stock price of $0.48 is trading 68.8% below its estimated GF Value™ of $1.55. GuruFocus considers Heron Therapeutics to be Possible Value Trap.

Key valuation signals for LTS:0J4V:

  • FFO:
  • GF Value™: $1.55 vs. price of $0.48 (68.8% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the LTS:0J4V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Heron Therapeutics Business Description

Other Exchanges HRTX:USAAXD2:Germany
Address 100 Regency Forect Drive, Suite 300, Cary, NC, USA, 27518
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
50GF Score

Get the complete analysis for LTS:0J4V

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$1.55
GF Value